🔗 www.docwirenews.com/post/inhaled...
Not all COPD patients benefit from inhaled nitric oxide—but some do. A new randomized trial suggests a CT‑based vascular marker may identify responders, pointing to a distinct COPD endotype. 🔍 #pulmonology #pulmsky #COPD #nitricoxide